Lymph-node dissection in breast cancer

Langenbeck's Archives of Surgery

Volumn 385, Issue 4, 2000, Pages 236-245

  Bembenek, A ^a   Schlag, P M ^a  

^a Section of Pathology   (Germany)

Author keywords

Breast cancer; Lymph node dissection; Lymph node status; Lymphonodectomy; Sentinel node biopsy

Indexed keywords

BREAST TUMOR; CANCER STAGING; FEMALE; HUMAN; LYMPH NODE; LYMPHADENECTOMY; METHODOLOGY; PATHOLOGY; REVIEW;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; NEOPLASM STAGING;

EID: 0034230599     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004239900055     Document Type: Article

References (61)

1. O'Higgins N (1994) How I minimize morbidity in axillary dissection. Eur J Surg Oncol 20:80-81
2. Ball ABS, Waters R, Thomas M (1987) Formal axillary dissection. Br J Hosp Med 44:396-399
3. Riddell VH (1948) Radical mastectomy Br J Surg 36:108-129
4. Axelsson CK, Mouridsen HT, Zedeler K (1992) Axillary dissection of level-I and -II lymph nodes is important in breast cancer classification. Eur J Cancer 28:1415-1418
5. Cady B, Sears HF (1986) Usefulness and technique of axillary dissection in primary breast cancer. J Clin Oncol 4:623-624
6. Graversen HP, Blichert-Toft M, Andersen JA, Zedeler K (1988) Breast cancer: risk of axillary recurrence in nodal-negative patients following partial dissection of the axilla. Eur J Surg Oncol 14:407-412
7. Sosa JA, Diener-West M, Gusev Y, Choti MA, Lange JR, Dooley WC, Zeiger MA (1998) Association between extent of axillary lymph-node dissection and survival in patients with stage-I breast cancer. Ann Surg Oncol 5:140-149
8. Benson EA, Thorogood J (1986) The effect of surgical technique on local recurrence rates following mastectomy. Eur J Surg Oncol 12:267-271
9. Kissin M, Thompson E, Price A (1982) The inadequacy of axillary sampling in breast cancer. Lancet 1:1210-1212
10. Berg JW (1955) The significance of axillary node levels in the study of breast carcinoma. Cancer 8:776-778
11. Canavese G, Catturich A, Vecchio C, Tomei D, Gipponi M, Bruzzi B, Baddellino F (1998) Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer. Eur J Surg Oncol 24:104-109
12. Danforth DN, Findlay PA, McDonald HD, Lippman ME, Reichert CM. D'Angelo T, Gorrell CR, Gerber NL, Lichter AS, Rosenberg SA, De Moss ES (1986) Complete axillary dissection for stage I-II carcinoma of the breast. J Clin Oncol 4:655-662
13. Senofsky GM, Moffat FL, Davis K, Masri MM, Clark KC, Robinson DS, Sabates B, Ketcham (1991) Total axillary lymphadenectomy in the management. Arch Surg 126:1336-1342
14. Siegel BM, Mayzel KA, Love SM (1990) Level I and II dissection in the treatment of early-stage breast cancer. Arch Surg 125:1144-1447
15. Larson D, Weinstein M, Goldberg I, Silver B, Recht A, Cady B (1986) Edema of the arm as a function of the extent of axillary surgery in patients with stage I/II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 12:1575-1582
16. Aitken DR, Minton JP (1983) Complications associated with mastectomy. Surg Clin North Am 63:1331-1352
17. Kissin MW, Della Rovere GQ, Easton D, Westbury G (1986) Risk of lymphoedema following the treatment of breast cancer. Br J Surg 73:580-584
18. Dahl-Iversen E, Tobiassen T (1969) Radical mastectomy with sternal and supraclavicular dissection for mammary carcinoma. Ann Surg 170:889-891
19. Wangensteen OH, Lewis F, Arelge SW (1956) The extended or supraradical mastectomy for carcinoma of the breast. Surg Clin North Am 36:728-734
20. Fisher B (1981) A commentary on the role of the surgeon in primary breast cancer. Breast Cancer Res Treat 1:17-26
21. Hellman S, Harris J (1987) The appropriate breast carcinoma paradigm. Cancer Res 2:339-342
22. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, Deutsch M, Montague E, Margolese R, Foster R (1985) Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312:674-681
23. Harris JR, Osteen RT (1985) Patients with early breast cancer benefit from axillary treatment. Breast Cancer Res Treat 5:17-21
24. Langlands AO, Prescott RJ, Hamilton T (1980) A clinical trial in the management of operable cancer of the breast. Br J Surg 67:170-174
25. Baxter N, McCready D, Chapman JA, Fish E, Kahn H, Hanna W, Trudeau M, Lickley L (1996) Clinical behaviour of untreated axillary nodes after local treatment for primary breast cancer. Ann Surg Oncol 3:235-240
26. Barth A, Craig PH, Silverstein MJ (1997) Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 79:1918-1922
27. Fisher BJ, Perera FE, Cooke AL, Opeitum A, Venkatesan V, Dar AR, Stitt L (1997) Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence. Int J Oncol Biol Phys 38:541-550
28. Danforth DN, Zujewski J, O'Shaughnessy J, Riseberg D, Steinberg SM, Atee N, Noone M, Chow C, Chaudhry U, Lippman M, Jacobson J, Okunieff P, Cowan KH (1998) Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA, B breast cancer. Ann Surg Oncol 5:150-158
29. Hortobagyi GN, Blumenschein GR, Spanos W (1983) Multimodal treatment of locoregionally advanced breast cancer. Cancer 51:763
30. Machiavelli MR, Romero AO, Perez JE, Lacava JA, Dominguez ME, Rodriguez R, Barbieri MR, Acuna LA, Acuna JM, Langhi MJ, Amato S, Ortiz EH, Vallejo CT, Leone BA (1998) Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoad-juvant chemotherapy for locally advanced breast carcinoma. Cancer J Sci Am 4:125-131
31. Weidner N, Cady B, Goodson WH (1997) pathologic prognostic factors for patients with breast carcinoma. Surg Oncol Clin North Am 6:415-461
32. Cady B, Stone MD, Wayne J (1993) New therapeutic possibilities in primary invasive breast cancer. Ann Surg 218:338-349
33. Silverstein MJ, Waisman JR, Gamagami P (1990) Intraductal carcinoma of the breast (208 cases). Cancer 66:102-108
34. Parker RG, Berkbigler D, Rees K, Leung KW, Legorreta AP (1998) Axillary dissection in ductal carcinoma in situ. Am J Clin Oncol 21:109-110
35. Shetty MR, Reiman HM (1997) Tumor size and axillary metastases, a corralation ocurrence in 1244 cases of breast cancer between 1980 and 1995. Eur J Surg Oncol 23:139-141
36. International Breast Cancer Study Group (1990) Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 335:1565-1568
37. National Institutes of Health Consensus Panel (1992) Consensus statement: treatment of early-stage breast cancer. J Natl Cancer Inst Monogr 11:1-5
38. Early Breast Cancer Trialists' Collaborative Group (1988) Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. N Engl J Med 319:1681-1692
39. Goldhirsch A, Wood WC, Senn HJ, Glick A, Gelber RD (1995) International Consensus Panel on the Treatment of Primary Breast Cancer. Eur J Cancer 31A:1754-1759
40. Dees EC, Shulman LN, Souba W, Smith BL (1997) Does information from axillary dissection change treatment in clinically node negative patients with breast cancer? Ann Surg 226:279-287
41. Kiricuta CI, Tausch J (1992) A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer 69:2496-2501
42. Ravdin PM, De Laurentiis M, Vendely T, Clark GM (1994) Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst 86:1771-1775
43. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, Costa A, De Cicco C, Geraghty JG, Luini A, Sachini V, Veronesi P (1997) Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 349:1864-1867
44. Barnwell JM, Arredondo MA, Kollmorgen D, Gibbs JF, Lamonica D, Carson W, Zhang P, Winston J, Edge SB (1998) Sentinel-node biopsy in breast cancer. Ann Surg Oncol 5:126-130
45. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL (1995) Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222:394-401
46. Reum T, Kaisers H, Markwardt J, Haensch W, Hohenberger P, Schlag PM (1998) Axillaausrtiumung bei klinisch nodal-negativem Mammakarzinom. Dtsch Med Wochenschr 123:583-587
47. Krag DN, Weaver DL, Alex JC, Fairbank JT (1993) Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335-340
48. Lacour J, Le M, Caceres E, Koszarowski T, Veronesi U, Hill C (1983) Radical mastectomy versus radical mastectomy plus internal mammary dissection. Cancer 51:1941-1943
49. Veronesi U, Valagussa P (1981) Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 47:170-175
50. Recht A, Pierce SM, Abner A, Vicini F, Osteen RT, Love SM, Silver B, Harris JR (1991 ) Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 9:988-996
51. Donegan WL, Spratt JS (1995) Surgical management. In: Donegan WL, Spratt JS (eds) Cancer of the breast, 4th edn. Saunders, Philadelphia, pp 443-504
52. Kaija H, Maunu P (1995) Tangential breast irradiation with or without internal mammary chain irradiation: results of a randomized trial. Radiother Oncol 36:172-176
53. Veronesi U, Cascinelli N, Bufalino R (1983) Risk of internal mammary lymph-node metastases and its relevance on prognosis of breast cancer. Ann Surg 198:681-684
54. Cody HS III, Urban JA (1995) Internal mammary lymph node status - a major prognostic factor in axillary node negative breast cancer. Ann Surg Oncol 2:32-37
55. Gaglia P, Bussone R, Caldarola B, Lai M, Jayme A, Caldarola L (1987) The correlation between the spread of metastases by level in the axillary nodes and disease-free survival in breast cancer. A multifactorial analysis. Eur J Cancer Clin Oncol 23:849-854
56. Cancer Research Campaign Working Party (1980) Cancer research campaign (King's/Cambridge) trial for early breast cancer. Lancet 12:55-60
57. Cabanes PA, Salmon RJ, Vilcoq JR, Duaran JC, Fourquet A, Gautier C, Asselain B (1992) Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 339:1245-1248
58. Osborne MP, Ormiston N, Harmer CL, McKinna JA, Baker J, Greening P (1984) Breast conservation in the treatment of early breast cancer. Cancer 53:349-355
59. Wong JS, Recht A, Beard CJ, Busse PM, Cady B, Chaffey JT, Come S, Fam S, Kaelin C, Lingos TI, Nixon AJ, Shulman LN, Troyan S, Silver B, Harris JR (1997) Treatment outcome after tangential radiation therapy without axillary dissection in patients with early-stage breast cancer and clinically negative axillary nodes. Int J Radiat Oncol Biol Phys 39:915-920
60. Haffly BG, Ward B, Pathare P, Salem R, McKhann C, Beinfield M, Fischer D, Reiss M (1997) Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. J Clin Oncol 15:691-700
61. White RE, Vezeridis MP, Konstadoulakis M, Cole BF, Wanebo HJ (1996) Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for the treatment of T1a and T1b lesions. J Am Coll Surg 183:575-582